A workshop, sponsored by the Peterson Center on Healthcare and convened by the Institute of Medicine, will engage in a discussion of the issues, challenges, and approaches that present the greatest opportunity creating models of care for high-need patients.
The National Academy of Medicine is pleased to introduce the Innovation to Incubation (i2I) semiannual Health Innovators Speaker Series.
The Institute of Medicine Committee on Community-Based Solutions to Promote Health Equity in the United States will hold its first meeting in Washington, DC, at the Keck Center of the National Academies. The committee will hear from speakers on several subjects that are relevant to the statement of task. More information will be posted closer to the meeting date, including the agenda. Register >>
The first workshop of the Standing Committee for the Centers for Disease Control and Prevention Division of Strategic National Stockpile will take place February 4-5, 2016 at the Keck Center in Washington, DC.
The Institute of Medicine of the National Academies of Sciences, Engineering, and Medicine will convene a public workshop on February 10-11, 2016 to discuss the state of the science on the health effects of indoor exposure to particulate matter.
With the conclusion of last December’s International Summit on Human Gene Editing, the second component of the Human Gene Editing Initiative is now moving forward.
The first meeting of the Committee on Clinical Trials During the 2014-2015 Ebola Outbreak will take place on February 22 and February 23 in Room at the Keck Center in Washington, DC.
This IOM workshop will examine existing challenges in the development and adoption of these novel therapeutics and explore strategies to improve the process.
On March 2, 2016 the Roundtable on Health Literacy of the Institute of Medicine will conduct a workshop on Health Literacy and Precision Medicine: An Important Partnership. The workshop will feature invited presentations and discussions of the issues that surround the role of health literacy in the growing field of precision medicine.
While major strides have been made over the past two decades in basic neurosciences, the pace of translation into more effective treatments has eluded the field. Among the many factors contributing to this reality are the standard clinical trial methods that have barely changed, perhaps with the exception of increased use of electronic data acquisition and analysis.